Evidence map›Paper›PMID 41381813›Full record

ArticleScientific reports2025

Integrative severity scale for diabetic macular atrophy and ischemia using structural OCT and OCT angiography.

Miyo Yoshida, Tomoaki Murakami, Kenji Ishihara, Yuki Mori, Akitaka Tsujikawa

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Miyo YoshidaDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Shougoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Tomoaki MurakamiDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Shougoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan. mutomo@kuhp.kyoto-u.ac.jp.
Kenji IshiharaDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Shougoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Yuki MoriDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Shougoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Akitaka TsujikawaDepartment of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, 54 Shougoin Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.

Funding

Grant-in-Aid for Scientific Research of the Japan Society for the Promotion of Science 23K09004
6 · The paper itself

Abstract

We investigated the characteristics of neurovascular degeneration in diabetic retinopathy (DR) using optical coherence tomography (OCT) and OCT angiography (OCTA). En-face 3 × 3 mm OCTA images were obtained from 327 eyes of DR patients without macular edema. Nonperfusion squares (NPSs) were defined as 15 × 15-pixel regions lacking vascular signals. Neurovascular parameters were extracted from five subfields of the Early Treatment Diabetic Retinopathy Study grid. High-dimensional data were embedded into a two-dimensional space using Uniform Manifold Approximation and Projection, and clustering revealed three distinct groups: Mild, Intermediate, and Severe. Eyes with central subfield thickness (CST) < 246 μm were classified as having diabetic macular atrophy. The Mild group exhibited lower NPS counts, while the Intermediate group showed increased NPS counts in the deep layer. The Severe group had the highest NPS counts and the lowest CST, with a significant negative correlation between CST and superficial NPS counts (ρ = - 0.252, P = 0.039). Eyes with diabetic macular atrophy in the Severe group demonstrated higher NPS counts, worse visual acuity, and more frequent ellipsoid zone disruption compared to the Mild and Intermediate groups (P < 0.001). These findings suggest a pathological relationship between macular ischemia and retinal atrophy, offering new insights into DR progression.

Indexed as

Diabetic RetinopathyIschemiaMacula LuteaTomography, Optical CoherenceAgedAtrophyFemaleFluorescein AngiographyHumansMaleMiddle AgedSeverity of Illness IndexVisual AcuityDiabetic macular atrophyDiabetic macular ischemiaDiabetic retinopathyNeurodegenerationUniform manifold approximation and projection

Identifiers

PMID41381813
PMCPMC12808632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.